Found 12 matching trials
CMV CTLs in Neonates With CMV Infection PHASE2 Patients with moderate or severe CMV disease less than 21 days old who have...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation PHASE1 To assess the safety and biological efficacy of therapeutically administere...
Show More Location
Westmead Hospital
Learn More & Join Trial
Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy PHASE2 Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality...
Show More Location
Hospital Marques de Valdecilla
Learn More & Join Trial
CMV-CTL for the Treatment of CMV Infection After HSCT PHASE4 Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Show More Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
Learn More & Join Trial
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone PHASE3 Patients with refractory ADV or CMV infection post allogeneic stem cell tra...
Show More Location
Multiple Locations
Learn More & Join Trial
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection PHASE2 Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactur...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation PHASE2 The purpose of this study is to see how well transfusions of T-cells work i...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) PHASE2 CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodi...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients PHASE1 This phase I trial tests the feasibility and safety of genetically modified...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH) N/A Subjects have a type of blood cell cancer, other blood disease or a genetic...
Show More Status
No Longer Available
Location
Houston Methodist Hospital
Learn More & Join Trial